Frederick L. Locke, MD, discussed cema-cel's safety, efficacy, and potential for treating large B-cell lymphoma in earlier ...

A clinical team has spearheaded the use of CAR-T cell therapy for blood cancers. The researchers recently treated the first ...

The community of Mt. Washington came together Tuesday to support pediatric cancer patients and survivors. Seth’s Squad hosted its fifth annual blood drive, Rise of the Donor, in collaboration with the ...

If Anixa exercises its rights, Verdi and Anixa will collaborate on trials in the US, while Verdi will continue developing personalized vaccines in Europe.

Ajai Chari, MD, stresses the importance of making bispecific therapies more accessible at the community level to improve outcomes in multiple myeloma.

Researchers proposed changing the recommendations for universal driving restrictions after CAR T-cell infusion.

Equities researchers at StockNews.com started coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Get Free Report) in a research report issued on Sunday. The firm set a “hold” rating on the ...

Data incorporated for this study were collected from 9 centers in the UK focused on third-line and beyond chimeric antigen ...

Currently, 13 CAR-T treatments have received regulatory approval. Blood cancers have dominated the development pipeline of ...

CERo’s technology works by grafting onto patients’ own T-cells a receptor that binds to a naturally occurring human antigen ...

Now, as a scientist at the University of Pennsylvania, Charly is working to rewrite the future of cancer treatment.

In an early-stage clinical trial, the therapy nearly doubled the expected survival time of young patients. Still, experts ...